Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immuno-oncology
Biotech
Sanofi shrinks $6B biobucks deal with IGM
Sanofi is shrinking a collaboration with IGM Biosciences by half, shedding three cancer targets to focus on three immunology and inflammation targets.
Gabrielle Masson
Apr 17, 2024 11:05am
Gilead pays $43.5M for Xilio's early-phase IL-12 prospect
Mar 28, 2024 8:08am
BMS exits next-gen Yervoy pact, taking $300M in biobucks with it
Mar 12, 2024 7:07am
Ultimovacs' cancer vaccine flunks another checkpoint combo test
Mar 7, 2024 6:14am
Astellas bets more than $800M on Kelonia's delivery tech
Feb 15, 2024 6:30pm
Eisai’s Cheung takes top spot at NextPoint Therapeutics
Feb 1, 2024 10:40am